Contract with Customer, Liability, Noncurrent of IDEXX LABORATORIES INC /DE from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
IDEXX LABORATORIES INC /DE quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Contract with Customer, Liability, Noncurrent for the quarter ending 30 Sep 2025 was $31,051,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $31,051,000 +$4,278,000 +16% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $31,762,000 +$4,977,000 +19% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $26,819,000 -$1,224,000 -4.4% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $26,939,000 -$1,594,000 -5.6% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $26,773,000 -$943,000 -3.4% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $26,785,000 -$2,269,000 -7.8% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $28,043,000 -$2,396,000 -7.9% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $28,533,000 -$2,329,000 -7.5% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $27,716,000 -$7,026,000 -20% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $29,054,000 -$7,911,000 -21% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $30,439,000 -$8,790,000 -22% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $30,862,000 -$10,312,000 -25% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $34,742,000 -$5,649,000 -14% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $36,965,000 -$6,231,000 -14% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $39,229,000 -$5,004,000 -11% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $41,174,000 -$4,989,000 -11% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $40,391,000 -$7,835,000 -16% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $43,196,000 -$14,568,000 -25% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $44,233,000 -$4,809,000 -9.8% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $46,163,000 -$2,580,000 -5.3% 31 Dec 2020 10-K 16 Feb 2022 2021 FY
Q3 2020 $48,226,000 -$119,000 -0.25% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $57,764,000 +$5,635,000 +11% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $49,042,000 -$6,653,000 -12% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $48,743,000 -$11,954,000 -20% 31 Dec 2019 10-K 12 Feb 2021 2020 FY
Q3 2019 $48,345,000 -$14,202,000 -23% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $52,129,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $55,695,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $60,697,000 +$25,152,000 +71% 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $62,547,000 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q4 2017 $35,545,000 31 Dec 2017 10-K 15 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.